Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season.
Identifieur interne : 000339 ( Main/Exploration ); précédent : 000338; suivant : 000340Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season.
Auteurs : D. Viasus [Espagne] ; E. Cordero ; J. Rodríguez-Ba O ; J A Oteo ; A. Fernández-Navarro ; L. Ortega ; I. Gracia-Ahufinger ; M C Fari As ; E. García-Almodovar ; A. Payeras ; J R Pa O-Pardo ; E. Mu Ez-Rubio ; J. CarratalàSource :
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [ 1469-0691 ] ; 2012.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Antiviraux (administration et posologie), Durée du séjour (MeSH), Espagne (épidémiologie), Femelle (MeSH), Grippe humaine (anatomopathologie), Grippe humaine (complications), Grippe humaine (virologie), Grippe humaine (épidémiologie), Grossesse (MeSH), Humains (MeSH), Hôpitaux d'enseignement (MeSH), Jeune adulte (MeSH), Mâle (MeSH), Pandémies (MeSH), Pneumopathie virale (anatomopathologie), Pneumopathie virale (épidémiologie), Répartition par âge (MeSH), Résultat thérapeutique (MeSH), Soins de réanimation (statistiques et données numériques), Sous-type H1N1 du virus de la grippe A (isolement et purification), Sous-type H1N1 du virus de la grippe A (pathogénicité), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Ventilation artificielle (statistiques et données numériques), Études de cohortes (MeSH), Études prospectives (MeSH).
- MESH :
- administration et posologie : Antiviraux.
- anatomopathologie : Grippe humaine, Pneumopathie virale.
- isolement et purification : Sous-type H1N1 du virus de la grippe A.
- pathogénicité : Sous-type H1N1 du virus de la grippe A.
- statistiques et données numériques : Soins de réanimation, Ventilation artificielle.
- virologie : Grippe humaine.
- épidémiologie : Espagne, Grippe humaine, Pneumopathie virale.
- complications : Adolescent, Adulte, Adulte d'âge moyen, Durée du séjour, Femelle, Grippe humaine, Grossesse, Humains, Hôpitaux d'enseignement, Jeune adulte, Mâle, Pandémies, Répartition par âge, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de cohortes, Études prospectives.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Age Distribution (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Antiviral Agents (administration & dosage), Cohort Studies (MeSH), Critical Care (statistics & numerical data), Female (MeSH), Hospitals, Teaching (MeSH), Humans (MeSH), Influenza A Virus, H1N1 Subtype (isolation & purification), Influenza A Virus, H1N1 Subtype (pathogenicity), Influenza, Human (complications), Influenza, Human (epidemiology), Influenza, Human (pathology), Influenza, Human (virology), Length of Stay (MeSH), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Viral (epidemiology), Pneumonia, Viral (pathology), Pregnancy (MeSH), Prospective Studies (MeSH), Respiration, Artificial (statistics & numerical data), Spain (epidemiology), Treatment Outcome (MeSH), Young Adult (MeSH).
- MESH :
- chemical , administration & dosage : Antiviral Agents.
- complications : Influenza, Human.
- epidemiology : Influenza, Human, Pneumonia, Viral, Spain.
- isolation & purification : Influenza A Virus, H1N1 Subtype.
- pathogenicity : Influenza A Virus, H1N1 Subtype.
- pathology : Influenza, Human, Pneumonia, Viral.
- statistics & numerical data : Critical Care, Respiration, Artificial.
- virology : Influenza, Human.
- Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, Cohort Studies, Female, Hospitals, Teaching, Humans, Length of Stay, Male, Middle Aged, Pandemics, Pregnancy, Prospective Studies, Treatment Outcome, Young Adult.
Abstract
Although the influenza A (H1N1) 2009 virus is expected to circulate as a seasonal virus for some years after the pandemic period, its behaviour cannot be predicted. We analysed a prospective cohort study of hospitalized adults with influenza A (H1N1) 2009 pneumonia at 14 teaching hospitals in Spain to compare the epidemiology, clinical features and outcomes of influenza A (H1N1) 2009 pneumonia between the pandemic period and the first post-pandemic influenza season. A total of 348 patients were included: 234 during the pandemic period and 114 during the first post-pandemic influenza season. Patients during the post-pandemic period were older and more likely to have chronic obstructive pulmonary disease, chronic kidney disease and cancer than the others. Septic shock, altered mental status and respiratory failure on arrival at hospital were significantly more common during the post-pandemic period. Time from illness onset to receipt of antiviral therapy was also longer during this period. Early antiviral therapy was less frequently administered to patients during the post-pandemic period (22.9% versus 10.9%; p 0.009). In addition, length of stay was longer, and need for mechanical ventilation and intensive-care unit admission were significantly higher during the post-pandemic period. In-hospital mortality (5.1% versus 21.2%; p <0.001) was also greater during this period. In conclusion, significant epidemiological changes and an increased severity of influenza A (H1N1) 2009 pneumonia were found in the first post-pandemic influenza season. Physicians should consider influenza A (H1N1) 2009 when selecting microbiological testing and treatment in patients with pneumonia in the upcoming influenza season.
DOI: 10.1111/j.1469-0691.2011.03753.x
PubMed: 22264321
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season.</title><author><name sortKey="Viasus, D" sort="Viasus, D" uniqKey="Viasus D" first="D" last="Viasus">D. Viasus</name><affiliation wicri:level="3"><nlm:affiliation>Hospital Universitari de Bellvitge - IDIBELL, University of Barcelona, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitari de Bellvitge - IDIBELL, University of Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Cordero, E" sort="Cordero, E" uniqKey="Cordero E" first="E" last="Cordero">E. Cordero</name></author><author><name sortKey="Rodriguez Ba O, J" sort="Rodriguez Ba O, J" uniqKey="Rodriguez Ba O J" first="J" last="Rodríguez-Ba O">J. Rodríguez-Ba O</name></author><author><name sortKey="Oteo, J A" sort="Oteo, J A" uniqKey="Oteo J" first="J A" last="Oteo">J A Oteo</name></author><author><name sortKey="Fernandez Navarro, A" sort="Fernandez Navarro, A" uniqKey="Fernandez Navarro A" first="A" last="Fernández-Navarro">A. Fernández-Navarro</name></author><author><name sortKey="Ortega, L" sort="Ortega, L" uniqKey="Ortega L" first="L" last="Ortega">L. Ortega</name></author><author><name sortKey="Gracia Ahufinger, I" sort="Gracia Ahufinger, I" uniqKey="Gracia Ahufinger I" first="I" last="Gracia-Ahufinger">I. Gracia-Ahufinger</name></author><author><name sortKey="Fari As, M C" sort="Fari As, M C" uniqKey="Fari As M" first="M C" last="Fari As">M C Fari As</name></author><author><name sortKey="Garcia Almodovar, E" sort="Garcia Almodovar, E" uniqKey="Garcia Almodovar E" first="E" last="García-Almodovar">E. García-Almodovar</name></author><author><name sortKey="Payeras, A" sort="Payeras, A" uniqKey="Payeras A" first="A" last="Payeras">A. Payeras</name></author><author><name sortKey="Pa O Pardo, J R" sort="Pa O Pardo, J R" uniqKey="Pa O Pardo J" first="J R" last="Pa O-Pardo">J R Pa O-Pardo</name></author><author><name sortKey="Mu Ez Rubio, E" sort="Mu Ez Rubio, E" uniqKey="Mu Ez Rubio E" first="E" last="Mu Ez-Rubio">E. Mu Ez-Rubio</name></author><author><name sortKey="Carratala, J" sort="Carratala, J" uniqKey="Carratala J" first="J" last="Carratalà">J. Carratalà</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22264321</idno><idno type="pmid">22264321</idno><idno type="doi">10.1111/j.1469-0691.2011.03753.x</idno><idno type="wicri:Area/Main/Corpus">00325</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00325</idno><idno type="wicri:Area/Main/Curation">000325</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000325</idno><idno type="wicri:Area/Main/Exploration">000325</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season.</title><author><name sortKey="Viasus, D" sort="Viasus, D" uniqKey="Viasus D" first="D" last="Viasus">D. Viasus</name><affiliation wicri:level="3"><nlm:affiliation>Hospital Universitari de Bellvitge - IDIBELL, University of Barcelona, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitari de Bellvitge - IDIBELL, University of Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Cordero, E" sort="Cordero, E" uniqKey="Cordero E" first="E" last="Cordero">E. Cordero</name></author><author><name sortKey="Rodriguez Ba O, J" sort="Rodriguez Ba O, J" uniqKey="Rodriguez Ba O J" first="J" last="Rodríguez-Ba O">J. Rodríguez-Ba O</name></author><author><name sortKey="Oteo, J A" sort="Oteo, J A" uniqKey="Oteo J" first="J A" last="Oteo">J A Oteo</name></author><author><name sortKey="Fernandez Navarro, A" sort="Fernandez Navarro, A" uniqKey="Fernandez Navarro A" first="A" last="Fernández-Navarro">A. Fernández-Navarro</name></author><author><name sortKey="Ortega, L" sort="Ortega, L" uniqKey="Ortega L" first="L" last="Ortega">L. Ortega</name></author><author><name sortKey="Gracia Ahufinger, I" sort="Gracia Ahufinger, I" uniqKey="Gracia Ahufinger I" first="I" last="Gracia-Ahufinger">I. Gracia-Ahufinger</name></author><author><name sortKey="Fari As, M C" sort="Fari As, M C" uniqKey="Fari As M" first="M C" last="Fari As">M C Fari As</name></author><author><name sortKey="Garcia Almodovar, E" sort="Garcia Almodovar, E" uniqKey="Garcia Almodovar E" first="E" last="García-Almodovar">E. García-Almodovar</name></author><author><name sortKey="Payeras, A" sort="Payeras, A" uniqKey="Payeras A" first="A" last="Payeras">A. Payeras</name></author><author><name sortKey="Pa O Pardo, J R" sort="Pa O Pardo, J R" uniqKey="Pa O Pardo J" first="J R" last="Pa O-Pardo">J R Pa O-Pardo</name></author><author><name sortKey="Mu Ez Rubio, E" sort="Mu Ez Rubio, E" uniqKey="Mu Ez Rubio E" first="E" last="Mu Ez-Rubio">E. Mu Ez-Rubio</name></author><author><name sortKey="Carratala, J" sort="Carratala, J" uniqKey="Carratala J" first="J" last="Carratalà">J. Carratalà</name></author></analytic><series><title level="j">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</title><idno type="eISSN">1469-0691</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Age Distribution (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Antiviral Agents (administration & dosage)</term><term>Cohort Studies (MeSH)</term><term>Critical Care (statistics & numerical data)</term><term>Female (MeSH)</term><term>Hospitals, Teaching (MeSH)</term><term>Humans (MeSH)</term><term>Influenza A Virus, H1N1 Subtype (isolation & purification)</term><term>Influenza A Virus, H1N1 Subtype (pathogenicity)</term><term>Influenza, Human (complications)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (pathology)</term><term>Influenza, Human (virology)</term><term>Length of Stay (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (pathology)</term><term>Pregnancy (MeSH)</term><term>Prospective Studies (MeSH)</term><term>Respiration, Artificial (statistics & numerical data)</term><term>Spain (epidemiology)</term><term>Treatment Outcome (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Antiviraux (administration et posologie)</term><term>Durée du séjour (MeSH)</term><term>Espagne (épidémiologie)</term><term>Femelle (MeSH)</term><term>Grippe humaine (anatomopathologie)</term><term>Grippe humaine (complications)</term><term>Grippe humaine (virologie)</term><term>Grippe humaine (épidémiologie)</term><term>Grossesse (MeSH)</term><term>Humains (MeSH)</term><term>Hôpitaux d'enseignement (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (anatomopathologie)</term><term>Pneumopathie virale (épidémiologie)</term><term>Répartition par âge (MeSH)</term><term>Résultat thérapeutique (MeSH)</term><term>Soins de réanimation (statistiques et données numériques)</term><term>Sous-type H1N1 du virus de la grippe A (isolement et purification)</term><term>Sous-type H1N1 du virus de la grippe A (pathogénicité)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Ventilation artificielle (statistiques et données numériques)</term><term>Études de cohortes (MeSH)</term><term>Études prospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antiviraux</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Grippe humaine</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term><term>Pneumonia, Viral</term><term>Spain</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Influenza, Human</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Critical Care</term><term>Respiration, Artificial</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Soins de réanimation</term><term>Ventilation artificielle</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term><term>Grippe humaine</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Distribution</term><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Female</term><term>Hospitals, Teaching</term><term>Humans</term><term>Length of Stay</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Pregnancy</term><term>Prospective Studies</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Durée du séjour</term><term>Femelle</term><term>Grippe humaine</term><term>Grossesse</term><term>Humains</term><term>Hôpitaux d'enseignement</term><term>Jeune adulte</term><term>Mâle</term><term>Pandémies</term><term>Répartition par âge</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études de cohortes</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Although the influenza A (H1N1) 2009 virus is expected to circulate as a seasonal virus for some years after the pandemic period, its behaviour cannot be predicted. We analysed a prospective cohort study of hospitalized adults with influenza A (H1N1) 2009 pneumonia at 14 teaching hospitals in Spain to compare the epidemiology, clinical features and outcomes of influenza A (H1N1) 2009 pneumonia between the pandemic period and the first post-pandemic influenza season. A total of 348 patients were included: 234 during the pandemic period and 114 during the first post-pandemic influenza season. Patients during the post-pandemic period were older and more likely to have chronic obstructive pulmonary disease, chronic kidney disease and cancer than the others. Septic shock, altered mental status and respiratory failure on arrival at hospital were significantly more common during the post-pandemic period. Time from illness onset to receipt of antiviral therapy was also longer during this period. Early antiviral therapy was less frequently administered to patients during the post-pandemic period (22.9% versus 10.9%; p 0.009). In addition, length of stay was longer, and need for mechanical ventilation and intensive-care unit admission were significantly higher during the post-pandemic period. In-hospital mortality (5.1% versus 21.2%; p <0.001) was also greater during this period. In conclusion, significant epidemiological changes and an increased severity of influenza A (H1N1) 2009 pneumonia were found in the first post-pandemic influenza season. Physicians should consider influenza A (H1N1) 2009 when selecting microbiological testing and treatment in patients with pneumonia in the upcoming influenza season.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22264321</PMID><DateCompleted><Year>2012</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-0691</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2012</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title><ISOAbbreviation>Clin. Microbiol. Infect.</ISOAbbreviation></Journal><ArticleTitle>Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season.</ArticleTitle><Pagination><MedlinePgn>E55-62</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1469-0691.2011.03753.x</ELocationID><Abstract><AbstractText>Although the influenza A (H1N1) 2009 virus is expected to circulate as a seasonal virus for some years after the pandemic period, its behaviour cannot be predicted. We analysed a prospective cohort study of hospitalized adults with influenza A (H1N1) 2009 pneumonia at 14 teaching hospitals in Spain to compare the epidemiology, clinical features and outcomes of influenza A (H1N1) 2009 pneumonia between the pandemic period and the first post-pandemic influenza season. A total of 348 patients were included: 234 during the pandemic period and 114 during the first post-pandemic influenza season. Patients during the post-pandemic period were older and more likely to have chronic obstructive pulmonary disease, chronic kidney disease and cancer than the others. Septic shock, altered mental status and respiratory failure on arrival at hospital were significantly more common during the post-pandemic period. Time from illness onset to receipt of antiviral therapy was also longer during this period. Early antiviral therapy was less frequently administered to patients during the post-pandemic period (22.9% versus 10.9%; p 0.009). In addition, length of stay was longer, and need for mechanical ventilation and intensive-care unit admission were significantly higher during the post-pandemic period. In-hospital mortality (5.1% versus 21.2%; p <0.001) was also greater during this period. In conclusion, significant epidemiological changes and an increased severity of influenza A (H1N1) 2009 pneumonia were found in the first post-pandemic influenza season. Physicians should consider influenza A (H1N1) 2009 when selecting microbiological testing and treatment in patients with pneumonia in the upcoming influenza season.</AbstractText><CopyrightInformation>© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viasus</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hospital Universitari de Bellvitge - IDIBELL, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cordero</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Rodríguez-Baño</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Oteo</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Fernández-Navarro</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ortega</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Gracia-Ahufinger</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Fariñas</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>García-Almodovar</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Payeras</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Paño-Pardo</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Muñez-Rubio</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Carratalà</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><CollectiveName>Novel Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Microbiol Infect</MedlineTA><NlmUniqueID>9516420</NlmUniqueID><ISSNLinking>1198-743X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006784" MajorTopicYN="N">Hospitals, Teaching</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Garcia-Vidal</LastName><ForeName>Carolina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niubó</LastName><ForeName>Jordi</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gudiol</LastName><ForeName>Francesc</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pachón</LastName><ForeName>Jerónimo</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osorio</LastName><ForeName>Guiovana</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gutiérrez</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernández-Cuencia</LastName><ForeName>Felipe</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gálvez</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>García-Álvarez</LastName><ForeName>Lara</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martínez-Montauti</LastName><ForeName>Joaquín</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torre-Cisneros</LastName><ForeName>Julián</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Casal</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Causse</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gutiérrez-Aroca</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lara</LastName><ForeName>Rosario</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivero</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gutiérrez-Cuadra</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanjuan</LastName><ForeName>María Victoria</ForeName><Initials>MV</Initials></Investigator><Investigator ValidYN="Y"><LastName>González-Fernández</LastName><ForeName>José Luis</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramírez</LastName><ForeName>Adria</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marinescu</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riera</LastName><ForeName>Melchor</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>González-Micheloud</LastName><ForeName>Adriana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caro-Bragado</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romero-Gómez</LastName><ForeName>María</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Portero-Azorín</LastName><ForeName>Francisca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramos-Martínez</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Molina-Ruiz</LastName><ForeName>Rosa María Malo</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agud</LastName><ForeName>María</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Segura</LastName><ForeName>Ferrín</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>López-Medrano</LastName><ForeName>Francisco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moreno</LastName><ForeName>Asunción</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcos</LastName><ForeName>María Ángeles</ForeName><Initials>MÁ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pumarola</LastName><ForeName>Tomás</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Linares</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22264321</ArticleId><ArticleId IdType="doi">10.1111/j.1469-0691.2011.03753.x</ArticleId><ArticleId IdType="pii">S1198-743X(14)61644-X</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Catalogne</li></region><settlement><li>Barcelone</li></settlement></list><tree><noCountry><name sortKey="Carratala, J" sort="Carratala, J" uniqKey="Carratala J" first="J" last="Carratalà">J. Carratalà</name><name sortKey="Cordero, E" sort="Cordero, E" uniqKey="Cordero E" first="E" last="Cordero">E. Cordero</name><name sortKey="Fari As, M C" sort="Fari As, M C" uniqKey="Fari As M" first="M C" last="Fari As">M C Fari As</name><name sortKey="Fernandez Navarro, A" sort="Fernandez Navarro, A" uniqKey="Fernandez Navarro A" first="A" last="Fernández-Navarro">A. Fernández-Navarro</name><name sortKey="Garcia Almodovar, E" sort="Garcia Almodovar, E" uniqKey="Garcia Almodovar E" first="E" last="García-Almodovar">E. García-Almodovar</name><name sortKey="Gracia Ahufinger, I" sort="Gracia Ahufinger, I" uniqKey="Gracia Ahufinger I" first="I" last="Gracia-Ahufinger">I. Gracia-Ahufinger</name><name sortKey="Mu Ez Rubio, E" sort="Mu Ez Rubio, E" uniqKey="Mu Ez Rubio E" first="E" last="Mu Ez-Rubio">E. Mu Ez-Rubio</name><name sortKey="Ortega, L" sort="Ortega, L" uniqKey="Ortega L" first="L" last="Ortega">L. Ortega</name><name sortKey="Oteo, J A" sort="Oteo, J A" uniqKey="Oteo J" first="J A" last="Oteo">J A Oteo</name><name sortKey="Pa O Pardo, J R" sort="Pa O Pardo, J R" uniqKey="Pa O Pardo J" first="J R" last="Pa O-Pardo">J R Pa O-Pardo</name><name sortKey="Payeras, A" sort="Payeras, A" uniqKey="Payeras A" first="A" last="Payeras">A. Payeras</name><name sortKey="Rodriguez Ba O, J" sort="Rodriguez Ba O, J" uniqKey="Rodriguez Ba O J" first="J" last="Rodríguez-Ba O">J. Rodríguez-Ba O</name></noCountry><country name="Espagne"><region name="Catalogne"><name sortKey="Viasus, D" sort="Viasus, D" uniqKey="Viasus D" first="D" last="Viasus">D. Viasus</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000339 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000339 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:22264321
|texte= Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22264321" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |